|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.80 EUR | +2.20% |
|
+2.78% | +23.75% |
| 11:00am | Bayer Cleared to Offer Stryax After EPA Registers Dicamba Herbicides | DJ |
| 07/02 | BAYER AG : Gets a Buy rating from Barclays | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 53.15B | |||||
| 947B | |||||
| 578B | |||||
| 395B | |||||
| 367B | |||||
| 303B |
- Stock Market
- Equities
- BAYN Stock
- Charts Bayer AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition